KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Acquisitions (2016 - 2025)

Quest Diagnostics (DGX) has disclosed Acquisitions for 16 consecutive years, with $50.0 million as the latest value for Q4 2025.

  • Quarterly Acquisitions fell 86.95% to $50.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $101.0 million through Dec 2025, down 83.99% year-over-year, with the annual reading at $101.0 million for FY2025, 95.33% down from the prior year.
  • Acquisitions hit $50.0 million in Q4 2025 for Quest Diagnostics, up from $34.0 million in the prior quarter.
  • In the past five years, Acquisitions ranged from a high of $578.0 million in Q2 2023 to a low of $1.0 million in Q2 2022.
  • Historically, Acquisitions has averaged $132.4 million across 5 years, with a median of $65.0 million in 2021.
  • Biggest five-year swings in Acquisitions: tumbled 99.57% in 2022 and later surged 57700.0% in 2023.
  • Year by year, Acquisitions stood at $80.0 million in 2021, then crashed by 52.5% to $38.0 million in 2022, then tumbled by 94.74% to $2.0 million in 2023, then skyrocketed by 19050.0% to $383.0 million in 2024, then tumbled by 86.95% to $50.0 million in 2025.
  • Business Quant data shows Acquisitions for DGX at $50.0 million in Q4 2025, $34.0 million in Q3 2025, and $17.0 million in Q2 2025.